Recent Updates
Recently added Catalysts
NAUT Positive Sentiment

Nautilus Biotechnology to Participate in Upcoming August Investor Conferences

Friday, August 4, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Nautilus Biotechnology, Inc. (NASDAQ: NAUT) has announced its participation in several upcoming investor conferences, including the Canaccord 43rd Annual Growth Conference and the UBS MedTech, Tools and Genomics Summit 2023. Management is set to participate in a panel discussion on the future of proteomics and will hold one-on-one meetings with investors. This involvement underscores the company's commitment to advancing its innovative protein analysis platform and its efforts to engage with the investment community.
Price reaction · baseline $3.14 (2023-08-03 close) · hit after-hours · 1 other NAUT headline(s) in the window, move may be shared
day 0 close · peak
+1.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in prestigious investor conferences highlights Nautilus's growth potential.
  • Engagement with investors through 1x1 meetings may strengthen investor relations.
  • Focus on pioneering a single-molecule protein analysis platform presents unique market opportunities.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
MDMA
Phase 2 · Post-Traumatic Stress Disorder

Full Press Release Details

SEATTLE, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences:
Canaccord 43rd Annual Growth Conference in Boston, MA
Management will participate in “The Next Generation of Proteomics from the Research and Clinical Perspectives” Panel on Thursday, August 10th at 10:00 a.m. Eastern Time
UBS MedTech, Tools and Genomics Summit 2023 in Dana Point, CA
Management will host 1x1 investor meetings on Tuesday, August 15th
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Frequently Asked Questions

What is Nautilus Biotechnology, Inc. known for?

Nautilus is known for its single-molecule protein analysis platform.

Which investor conferences will Nautilus participate in 2023?

Nautilus will participate in the Canaccord and UBS MedTech conferences.

What panel will Nautilus be part of at the Canaccord conference?

Nautilus will join 'The Next Generation of Proteomics' panel on August 10th.

Where are Nautilus' headquarters located?

Nautilus has headquarters in Seattle, WA and research in San Carlos, CA.

What is Nautilus' mission in proteomics?

Nautilus aims to democratize access to the proteome for health advancements.

ShareAdd on Google
Tags: NAUT Viatris Investor Conferences Healthcare Nautilus Biotechnology proteomics investor conference biotechnology
Last updated: Aug 4, 2023

Biotech snapshot

Cash runway
$143M liquidity · $4M/mo burn
~29 mo
Minimal dilution risk
Lead asset
MDMAPhase 2
Post-Traumatic Stress Disorder →